
The Alzheimer's Association has published new clinical practice guidelines to improve the detection, diagnosis, and disclosure of mild cognitive impairment (MCI) and dementia due to Alzheimer's disease (AD) and related disorders. This article emphasizes the vital role of neuropsychological evaluation within the guidelines, particularly in supporting early and accurate diagnosis, staging, and monitoring disease progression. Neuropsychologists contribute to tailoring individualized recommendations for patients and their care teams, thereby enhancing overall care and management in primary and specialty care settings.
Like
Save
Share